Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): SFB219 Introduction Patients with chronic kidney disease (CKD) have a significantly elevated cardiovascular risk, which is primarily due to premature vascular aging with arterial calcification - a substantial public health burden. Calcifying extracellular vesicles (EVs) are required for the onset and progression of calcification. Endocytosis and exocytosis are important for EV genesis and cargo loading, thus controlling EV release and propensities. Purpose We aim to investigate endocytosis, endosomal ripening, and exocytosis as critical mechanisms of EV-dependent mineralization. Methods and Results First, we characterized EVs from calcifying vascular smooth muscle cells (SMCs) compared to control SMCs. Western blot analysis revealed an increase in tissue nonspecific alkaline phosphatase (TNAP) among calcifying EVs but not in flotillin abundance. When compared to control EVs, calcifying EVs showed higher TNAP activity. Flow cytometry and a turbidity assay were then used to evaluate EV mineral cargo and aggregation potential. Compared to the control, EVs produced from SMCs cultivated under calcifying conditions had 5-fold more mineral-positive EVs (p=0.004) and a 3-fold higher nucleation potential (p<0.001). Next, endocytosis was blocked by targeting Dynamin-1 and –2, which inhibited caveolin- and clathrin-dependent endocytosis (Dynasore hydrate), or targeting clathrin-terminal domain, which inhibited solely clathrin-dependent endocytosis (Pitstop 2). Dynasore reduced matrix mineralization dose-dependently and lowered mineral-positive EVs by 18%, whereas Pitstop 2 had no effect, suggesting a role of caveolin-dependent endocytosis in EV-mediated calcification. Indeed, Cav-1 silencing inhibited matrix mineralization and Cav-1 protein was more abundant in calcifying EVs than in control EVs. Dynasore and Pitstop-2 did not affect the EV number measured by nanoparticle tracking analysis. Inhibition of endosomal ripening by Rab7 inhibition did not affect SMC calcification. Exocytosis was inhibited by Rab27a inhibition, which reduced mineral deposition (-32%, p=0.017) without affecting EV mineral or EV quantity. Conclusion EVs released from calcifying SMCs showed a higher abundance of mineral and TNAP proteins, suggesting a role in mineral transport and deposition. Our data suggest that caveolin-dependent endocytosis is essential in EV-mediated SMC calcification. Mineral cargo in EVs is independent of Rab7 and Rab27a pathways.

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Extracellular vesicles in chronic kidney disease: diagnostic and therapeutic roles

Advances in the mechanisms of vascular calcification in chronic kidney disease

Vascular calcification in CKD: New insights into its mechanisms

The Role of Small Extracellular Vesicle Non-Coding RNAs in Kidney Diseases

Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease

High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

Role of endothelial cells in vascular calcification

Matrix Vesicles as a Therapeutic Target for Vascular Calcification

The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification

Frontier role of extracellular vesicles in kidney disease

The functional role of cellular senescence during vascular calcification in chronic kidney disease

Role of Mitochondrial Dysfunction in CKD-related Vascular Calcification: From Mechanisms to Therapeutics

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects

Vascular calcification: from the perspective of crosstalk

Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches

Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification

Cellular Crosstalk in the Vascular Wall Microenvironment: The Role of Exosomes in Vascular Calcification

Caveolin-dependent endocytosis regulates arterial calcification

The role of mitochondria in vascular calcification

Prevention and Cure of Vascular Calcification in Patients with Chronic Kidney Disease